Dr. Diane L. Berry has been Vice President of Global Health Policy and Government Affairs at Sarepta Therapeutics, Inc. since December 2011. Dr. Berry serves as Senior Science Advisor at the international law firm McKenna, Long and Aldridge. Dr. Berry is a skilled biochemical engineer. Her previous experience includes working at the US Department of Defense Chemical and Biological Defense Program with a focus on chemical/biological detection, protection, decontamination and medical countermeasures. Dr. Berry is a member of the Government Contracts Practice of McKenna Long & Aldridge LLP. Dr. Berry worked for the federal government overseeing and implementing science and technology and public health activities, including CBRN defense efforts, across the legislative and executive branches.
Dr. Berry served as a Subcommittee Staff Director and Senior Professional Staff Member for the House Committee on Homeland Security and worked at the Department of Homeland Security in the Office of Health Affairs in leadership roles including Chief Scientist, Director of Threat Characterization and Countermeasures, and Senior Biodefense Advisor. Dr. Berry has been a Member of Scientific Advisory Board at Biophage Pharma Inc. since April 2005. She was a Science & Technology Policy Fellow through the American Association for the Advancement of Science. Dr. Berry earned her Ph.D. in chemical engineering from Northwestern University and received her B.S. and M.S. in chemical/biochemical engineering from Tufts University.